Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SRPT Sarepta Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $18.52 -0.6% | $15.35 +3.1% |
| StockIQ Score | 40D Weak Risk: High | 38F Weak Risk: High |
| Technical | 32F | 24F |
| Fundamental | 38F | 35F |
| Growth | 48D+ | 50C- |
| Fair Value | 38F | 38F |
| News | 38F | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Sarepta Therapeutics (SRPT) has a slightly stronger overall investor and fundamental score (40 vs. 38, 38 vs. 35), while Ascentage Pharma (AAPG) leads in growth (50 vs. 48). Both share the same weak rating and valuation score (38), but AAPG’s technical score is notably lower (24 vs. 32). Growth is AAPG’s clear strength.
